Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes

PURPOSE: Increasing cohorts of patients present with diabetic cardiomyopathy, and with no targeted options, treatment often rely on generic pharmaceuticals such as β‐blockers. β‐blocker efficacy is heterogenous, with second generation β‐blocker metoprolol selectively inhibiting β(1)‐AR, while third...

Descripción completa

Detalles Bibliográficos
Autores principales: Bussey, Carol T., Babakr, Aram A., Iremonger, Rachael R., van Hout, Isabelle, Wilkins, Gerard T., Lamberts, Regis R., Erickson, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070160/
https://www.ncbi.nlm.nih.gov/pubmed/32170823
http://dx.doi.org/10.14814/phy2.14394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070160/
https://www.ncbi.nlm.nih.gov/pubmed/32170823
http://dx.doi.org/10.14814/phy2.14394

Ejemplares similares